Anhydrovinblastine
Term · Oncology and biomedicine · MLC-T-ONC-000552
An anticancer drug that belongs to the family of drugs called mitotic inhibitors.
A semisynthetic derivative of the vinca alkaloid vinblastine, with potential antineoplastic activity. Like vinblastine, anhydrovinblastine targets and binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and causing tumor cell cycle arrest in the M phase.
| Identifier | MLC-T-ONC-000552 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | AVLB |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-000552",
"term": "Anhydrovinblastine",
"field": "Oncology and biomedicine",
"definitions": [
"An anticancer drug that belongs to the family of drugs called mitotic inhibitors.",
"A semisynthetic derivative of the vinca alkaloid vinblastine, with potential antineoplastic activity. Like vinblastine, anhydrovinblastine targets and binds to tubulin and inhibits microtubule formation, resulting in disruption of mitotic spindle assembly and causing tumor cell cycle arrest in the M phase."
],
"abbreviation": "AVLB",
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/anhydrovinblastine/"
}
Record 1,133 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.